Breakthrough Medication Potentially Reversing Kidney Decline To Help Limit Or Avoid Dialysis And Kidney Transplant



UPDATE: Reata Pharmaceuticals, Inc. (a clinical-stage biopharmaceutical company) has announced that the possible medication to help limit and improve Kidney Decline - Bardoxolone Methyl - "produced significant increase in Kidney Function maintained through week 36," according to the Analytics Website, The Moveefy.

Recommended Reading: New Stem Cell Therapy Could Replace Need For Kidney Transplants

While this news appears promising, patients should always remain tentatively optimistic while possible breakthroughs conduct Human Testing. Reata Pharmaceuticals, Inc. focuses on identifying, developing, and commercializing product candidates for patients with rare and life-threatening diseases such as Chronic Kidney Disease.

Recommended Reading: Large Dialysis Organization Caught In Bribery Probe Reaches Agreement

The fact that there is new and promising kidney research that is being ushered through Human Trials, is good news for Chronic Kidney Disease and Dialysis patients who would like better options to lead higher quality lives. will continue to keep you updated on the latest. Also, for the most cutting edge breakthroughs, real-life patient deferment insights, and non-medical tools related to possible Dialysis Avoidance Strategies, if possible, Join KidneyBuzz CONNECT today (click here)! Space is limited!


ORIGINAL: Many Chronic Kidney Disease and Dialysis patients struggle to maintain Kidney Function to avoid Dialysis treatments altogether or limit their time on the machine. While some patients have identified various hacks to help maintain function, it has been widely regarded as highly unlikely to increase Kidney Function once it began to decline or moved into Stage 5. While KidneyBuzz does not endorse any possible breakthroughs, it does appear as though a new medication has potentially turned this wide-spread assumption on its head.

Recommended Reading: Technological Breakthrough May Be Precursor To Transplantable Bioengineered Kidneys Ending Dialysis

The experimental drug, Bardoxolone Methyl, has begun to be tested in patients to determine if it can, in fact, help to rebound Kidney Function in later stage Chronic Kidney Disease patients, according to CBS News (Denver). Early results appear very promising (see video below). 

Recommended Reading: Breakthrough Treatment Has Proven To Eliminate Need For Immunosuppressants After Kidney Transplant

Lead by Dr. Geoffrey Block (Nephrologist), the medication has helped patients like Matt Hinerfeld regain Kidney Function before having to begin Dialysis. The good doctor said, after 12 weeks, Hinerfeld’s kidney function stopped declining and actually improved.

Recommended Reading: New Breakthrough For Commonly Used Dialysis Drug Could Be A Game Changer For CKD Patients

Dr. Block noted, “We’ve never studied anything like this that makes kidneys better." Since beginning taking Bardoxolone Methyl, Hinerfeld says he feels normal again. He’s happy to continue taking a pill a day for as long as necessary. “I kind of have chills right now talking about it,” said Matt. “I don’t often say this, but I feel blessed." 

Recommended Reading: Kidney Breakthrough May End Need For Kidney Donors In The Case Of Chronic Kidney Disease Patients

Could this medication help patients who have already begun Dialysis? We will have to wait and see as further studies are in the works. If you would like more information about this breakthrough research and other therapies that may help Chronic Kidney Disease and Dialysis patients to improve Kidney Function, then complete the below form:

Name *

What stage of Kidney Failure are you at currently? What would you do with improved Kidney Function? Share your experience and insights with the over 72,000 Friends who have liked on Facebook (click here). Also, follow the over 250,000+ monthly individual viewers who visit regularly for the latest daily news and information which teach those with Chronic Kidney Disease, Dialysis, Kidney Transplant, Diabetes, and Hypertension how to better manage and improve their lives. Erica Ashley Jenkins (Dialysis Nurse) said, "Hello I just wanted to let you know I work in a dialysis clinic and over half of our clinic reads this page, we enjoy everything you put on and love to have new information. My patients are very grateful."


Most Popular Stories: